Non-linear association between aspartate aminotransferase to alanine aminotransferase ratio and mortality in critically ill older patients: A retrospective cohort study.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 16 05 2023
accepted: 18 10 2023
medline: 6 11 2023
pubmed: 2 11 2023
entrez: 2 11 2023
Statut: epublish

Résumé

The aspartate aminotransferase to alanine aminotransferase (AST/ALT) ratio has been shown to be associated with poor clinical outcomes across various patient groups. However, little is unclear about the association between the two in critically ill older patients. Therefore, we aim to investigate the association of the AST/ALT ratio with hospital mortality in this special population. In this retrospective cohort study, we extracted elderly patients (age ≥ 65 years) from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database. The primary outcome was in-hospital mortality. The association between the AST/ALT ratio and hospital mortality was studied using univariable and multivariable Cox regression analysis, as well as restricted cubic splines (RCS). Survival analysis was performed using the Kaplan-Meier (KM) method according to the AST/ALT ratio. Among the 13,358 eligible patients, the mean age was 77.6 years, 7,077 patients (52.9%) were male, and 2,511 patients (18.8%) died in hospital. The AST/ALT ratio was found to be independently associated with in-hospital mortality (HR = 1.05, 95% CI: 1.01-1.09, P = 0.022) after adjusting for potential confounders. Furthermore, a non-linear relationship and saturation effect were observed between them, with the inflection point being 1.80. When the AST/ALT ratio was less than 1.80, we found that every 1 unit increase in the AST/ALT ratio resulted in a 39% increased risk of in-hospital mortality (HR = 1.39, 95% CI: 1.18-1.64, P < 0.001). However, when the AST/ALT ratio was greater than 1.80, the association became saturated (HR = 1.01, 95% CI: 0.96-1.07, P = 0.609). Sensitivity and subgroup analyses showed the results were robust. In critically ill older patients, the association between the AST/ALT ratio and in-hospital mortality was non-linear and showed a saturation effect. An elevated AST/ALT ratio was significantly associated with increased in-hospital mortality when the AST/ALT ratio was less than 1.80.

Sections du résumé

BACKGROUND
The aspartate aminotransferase to alanine aminotransferase (AST/ALT) ratio has been shown to be associated with poor clinical outcomes across various patient groups. However, little is unclear about the association between the two in critically ill older patients. Therefore, we aim to investigate the association of the AST/ALT ratio with hospital mortality in this special population.
METHODS
In this retrospective cohort study, we extracted elderly patients (age ≥ 65 years) from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database. The primary outcome was in-hospital mortality. The association between the AST/ALT ratio and hospital mortality was studied using univariable and multivariable Cox regression analysis, as well as restricted cubic splines (RCS). Survival analysis was performed using the Kaplan-Meier (KM) method according to the AST/ALT ratio.
RESULTS
Among the 13,358 eligible patients, the mean age was 77.6 years, 7,077 patients (52.9%) were male, and 2,511 patients (18.8%) died in hospital. The AST/ALT ratio was found to be independently associated with in-hospital mortality (HR = 1.05, 95% CI: 1.01-1.09, P = 0.022) after adjusting for potential confounders. Furthermore, a non-linear relationship and saturation effect were observed between them, with the inflection point being 1.80. When the AST/ALT ratio was less than 1.80, we found that every 1 unit increase in the AST/ALT ratio resulted in a 39% increased risk of in-hospital mortality (HR = 1.39, 95% CI: 1.18-1.64, P < 0.001). However, when the AST/ALT ratio was greater than 1.80, the association became saturated (HR = 1.01, 95% CI: 0.96-1.07, P = 0.609). Sensitivity and subgroup analyses showed the results were robust.
CONCLUSION
In critically ill older patients, the association between the AST/ALT ratio and in-hospital mortality was non-linear and showed a saturation effect. An elevated AST/ALT ratio was significantly associated with increased in-hospital mortality when the AST/ALT ratio was less than 1.80.

Identifiants

pubmed: 37917784
doi: 10.1371/journal.pone.0293749
pii: PONE-D-23-14780
pmc: PMC10621830
doi:

Substances chimiques

Alanine Transaminase EC 2.6.1.2
Aspartate Aminotransferases EC 2.6.1.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0293749

Informations de copyright

Copyright: © 2023 Yang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Diabetes Metab Syndr Obes. 2021 Sep 07;14:3831-3837
pubmed: 34522109
Kathmandu Univ Med J (KUMJ). 2013 Jul-Sep;11(43):233-6
pubmed: 24442172
Med Intensiva. 2014 Jan-Feb;38(1):21-32
pubmed: 23462427
JAMA. 2016 Apr 26;315(16):1726-34
pubmed: 27115377
J Am Coll Nutr. 2019 Nov-Dec;38(8):661-669
pubmed: 31075051
Nutrients. 2021 Jul 05;13(7):
pubmed: 34371823
J Clin Med. 2018 Nov 23;7(12):
pubmed: 30477196
Nutrients. 2021 Aug 12;13(8):
pubmed: 34444924
J Gastroenterol Hepatol. 2022 May;37(5):946-953
pubmed: 35233823
JAMA. 2020 Apr 21;323(15):1478-1487
pubmed: 32207816
Front Med (Lausanne). 2021 Nov 17;8:732039
pubmed: 34869425
Gut. 2010 Sep;59(9):1265-9
pubmed: 20801772
Clin Chim Acta. 2022 Oct 1;535:75-81
pubmed: 35985502
Crit Care Med. 2003 Apr;31(4):1048-52
pubmed: 12682471
Singapore Med J. 2023 Oct;64(10):640-644
pubmed: 37861645
Liver Int. 2014 Feb;34(2):296-304
pubmed: 24219360
World J Surg. 2019 Feb;43(2):466-475
pubmed: 30238387
Scand J Gastroenterol. 2023 Apr;58(4):392-402
pubmed: 36259154
Cardiol Res Pract. 2020 Mar 23;2020:8743548
pubmed: 32274211
Dis Markers. 2020 Nov 04;2020:8826318
pubmed: 33204363
Medicine (Baltimore). 2016 Oct;95(43):e4821
pubmed: 27787357
Sci Rep. 2021 Jun 7;11(1):11957
pubmed: 34099767
J Gerontol A Biol Sci Med Sci. 2010 Jul;65(7):712-7
pubmed: 20498223
Subcell Biochem. 2019;91:21-43
pubmed: 30888648
Am J Cardiol. 2021 Jan 15;139:64-70
pubmed: 33115639
Ann Intensive Care. 2023 Feb 11;13(1):7
pubmed: 36764980
BMC Cardiovasc Disord. 2017 Jan 28;17(1):43
pubmed: 28129742
Lipids Health Dis. 2012 Jun 19;11:78
pubmed: 22713601
Int J Epidemiol. 2014 Feb;43(1):187-201
pubmed: 24585856
Eur J Clin Invest. 2021 Jan;51(1):e13427
pubmed: 33043447
Intensive Care Med. 2018 Nov;44(11):1896-1903
pubmed: 30255319
Intensive Care Med. 2017 Sep;43(9):1319-1328
pubmed: 28238055
Crit Care Med. 2020 Apr;48(4):466-474
pubmed: 32205592
J Gerontol A Biol Sci Med Sci. 2018 Jun 14;73(7):925-930
pubmed: 28633440
Public Health Nutr. 2015 Jul;18(10):1839-46
pubmed: 25482035
J Thorac Dis. 2018 Aug;10(8):4957-4965
pubmed: 30233870
Medicine (Baltimore). 2021 Aug 6;100(31):e26693
pubmed: 34397804

Auteurs

Hua Yang (H)

Department of Cardiology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Department of Cardiology, Handan First Hospital, Handan, Hebei, China.

Limin Meng (L)

Department of Cardiology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Department of Cardiology, Handan First Hospital, Handan, Hebei, China.

Shuanli Xin (S)

Department of Cardiology, Handan First Hospital, Handan, Hebei, China.

Chao Chang (C)

Department of Cardiology, Handan First Hospital, Handan, Hebei, China.

Xiufeng Zhao (X)

Department of Cardiology, Handan First Hospital, Handan, Hebei, China.

Bingyan Guo (B)

Department of Cardiology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH